头豹短报告| 2024/03 www.leadleo.com 2024年 中国人形机器人行业研究：关注人形机器 人产业链机遇 Chinese Humanoid Robot Industry 中国人型ロボット産業 （精简版） 报告标签：人形机器人、特斯拉、空心杯电机 撰写人：张诗悦 ...

头豹短报告| 2024/03 www.leadleo.com 2024年 中国人形机器人行业研究：关注人形机器 人产业链机遇 Chinese Humanoid Robot Industry 中国人型ロボット産業 （精简版） 报告标签：人形机器人、特斯拉、空心杯电机 撰写人：张诗悦 ...

假肢行业 规模 中国 市场 测算逻辑模 型 ...

Leadleo.com 假肢行业：重塑生活的力量，智能假肢技术的飞跃 与行业前景展望 头豹词条报告系列 廖婧怡·头豹分析师 2024-05-24 未经平台授权，禁止转载 版权有问题？点此投诉 行业： 制造业/专用设备制造业/医疗设备制造/康复与保健类设备制造 工业制品/工业制造 行业定义 行业分类 行业特征 发展历程 假肢是用工程技术的手段和 按照截肢部位和结构的分类 非侵入式脑机接口技术提升 假肢行业 方法，为弥补截肢者或肢… 方式，假肢行业可以分为… 假肢功能与感知，中国假… 目前已达到 3个阶段 AI访谈 AI访谈 AI访谈 AI访谈 产业链分析 行业规模 政策梳理 竞争格局 假肢行业规模 假肢行业 上游分析 中游分析 下游分析 评级报告 1篇 相关政策 5篇 AI访谈 数据图表 AI访谈 AI访谈 SIZE数据 AI访谈 摘要 假肢是用工程技术的手段和方法，为弥补截肢者或肢体不完全缺损的肢体而专门设计和制作装配的人工假体，又 称“义肢”。中国假肢行业规模整体呈现上升趋势，2019年—2023年，假肢行业市场规模由50.35亿人民币元增 长至51.34亿人民币元，期间年复合增长率0.49%。侵入式脑机接 ...

行业概览| 2024/2 www.leadleo.com 2024年中国网络音频行业： “耳朵经济”进入全场景时代 2024 China Network Audio Industry ： The “Ear Economy" Enters the Era of All-scene 2024 年中国ネットワークオーディオ産業： 耳の経済」はオールシーンの時代に突入する （摘要版） 报告标签：播客、有声书、广播剧、AI音频生成、喜马拉雅 主笔人：程希 ...

Investment Rating - The report does not provide a specific investment rating for the factory automation control industry Core Insights - The factory automation control industry in China is crucial for upgrading the manufacturing sector from low-end to mid-high end, with significant market potential driven by rising labor costs and declining workforce participation [4][31] - The industry is expected to grow steadily, with a projected compound annual growth rate (CAGR) of 10.7% from 2023 to 2028, reaching a market size of 447.6 billion yuan by 2028 [4][31] - Domestic manufacturers are increasingly gaining market share, with notable companies like Inovance Technology and Zhongkong Technology leading the charge in technological innovation and product acceptance [4][32] Industry Definition - Factory automation control refers to the application of automation technology in mechanical manufacturing processes to enhance production efficiency and quality while reducing labor reliance [5] Industry Classification - The factory automation control industry can be categorized into OEM-driven (equipment manufacturers) and project-driven (end-user driven) markets [6] Industry Characteristics - The industry exhibits significant cyclicality, with a typical cycle lasting 3-4 years, currently at the bottom of the fourth cycle, with expectations for a new cycle to begin in 2024 [9][10] - There is a notable trend towards domestic substitution, with local manufacturers rapidly advancing in technology and market share [11][12] Industry Development History - The factory automation control industry has evolved through three stages: the nascent stage (1950-1960), the initiation stage (1961-2000), and the rapid development stage (2001-2024), currently in the latter phase [13][14][16] Industry Chain Analysis - The upstream of the industry includes raw materials and components such as electronic components and power electronic devices, with key players like Qualcomm and HiSilicon [17][21] - The midstream consists of industrial automation manufacturers, with leading companies including Inovance Technology and Yaskawa Electric [23][24] - The downstream applications are diverse, with significant market shares in sectors like chemicals, petrochemicals, and electricity [29][28] Market Size - The market size of the factory automation control industry grew from 183 billion yuan in 2018 to 269.4 billion yuan in 2023, with a CAGR of 8.04% [31][32] Policy Overview - Various policies have been implemented to support the development of the factory automation control industry, focusing on advanced manufacturing and energy efficiency [36][37][38] Competitive Landscape - The global competitive landscape shows that while China is a technology follower, it has made significant strides in the mid-low end of the factory automation control market, with domestic companies like Inovance Technology gaining substantial market share [42][45]

非小细胞肺癌靶向治疗行业 中国 市 规模 场 测算逻辑模型 ...

低空经济深度解读： eVTOL赛道市场规模和创新价值分析 In-Depth Analysis of the Low-Altitude Economy: Market Size and Innovation Value of the eVTOL Sector 报告标签：低空经济、 eVTOL、市场规模、商业价值 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹独有的高度机密性文件（在报告 中另行标明出处者除外）。未经头豹事先书面许可，任何人不得以任何方式擅自复制、再造、传播、出版、 引用、改编、汇编本报告内容，若有违反上述约定的行为发生，头豹保留采取法律措施，追究相关人员责任 的权利。头豹开展的所有商业活动均使用“头豹研究院”或“头豹”的商号、商标，头豹无任何前述名称之外的其 他商号或商标，也未授权或聘用其他任何第三方代表头豹开展商业活动。 www.leadleo.com 头豹研究院 1 专题研究| 2024/05 低空经济深度解读：eVTOL赛道市场规模和创新价值分析 摘要 头豹研究院谨此发布《低空经济深度解读： ◼ 中国政府大力发展低空经济 ...

Investment Rating - The report rates Connect Biopharma as a promising investment opportunity in the biopharmaceutical sector, particularly focusing on atopic dermatitis and asthma treatments [2]. Core Insights - Connect Biopharma has established a strong position in the biopharmaceutical industry through its innovative product pipeline and effective commercialization strategies, which have led to stable cash flow and enhanced market competitiveness [9][10]. - The company is well-positioned to capitalize on the growing demand for biologics in the treatment of autoimmune diseases, with a focus on self-immune markets along the Belt and Road Initiative [22][25]. Company Financial Performance - Connect Biopharma achieved a stable cash flow in 2023, with total cash and short-term investments decreasing to $120 million from $160 million in 2022 [10]. - The company's R&D expenditure was $51.9 million in 2023, down from $96.6 million in 2022, reflecting a strategic focus on cost management while maintaining innovation [10][12]. - The asset-liability ratio remains low at 6%-9%, significantly below the industry average of 30%-50%, indicating strong solvency and lower borrowing costs [14]. - The liquidity ratio is maintained above 10%, showcasing the company's robust short-term debt repayment capability [15]. - Revenue quality has improved, with a growth from 48.4% in 2021 to 104.5% in 2023, indicating a sustainable revenue outlook [16]. Business Layout - Connect Biopharma operates with a light asset model, avoiding heavy fixed asset burdens, which allows for a healthy cash flow state [18]. - The company has established a global presence with headquarters in California and a significant operational base in Suzhou, China, enhancing its market reach [19]. Product Pipeline - The core product pipeline includes CBP-201, targeting IL-4Ra for atopic dermatitis and asthma, and CBP-307, targeting S1P1 for ulcerative colitis and Crohn's disease, both showing significant clinical potential [20][21]. - CBP-201 has shown promising results in clinical trials, with plans for NDA submission in Q1 2024 [21][35]. Future Development Strategy - Connect Biopharma aims to enhance its R&D capabilities and expand its market share through strategic partnerships with pharmaceutical companies, focusing on autoimmune diseases [22][25]. - The company is exploring international markets, particularly in Southeast Asia and other Belt and Road countries, to leverage growth opportunities in the biopharmaceutical sector [22][27].

Leadleo.com 驱蚊用品：户外和母婴市场需求助推驱蚊用品行业 高速发展，龙头企业市场份额不断增长 头豹词条报 告系列 黄之婧·头豹分析师 2024-05-17 未经平台授权，禁止转载 版权有问题？点此投诉 行业： 批发和零售业/零售业/纺织、服装及日用品专门零售 消费品制造/家电家用 制造业 行业定义 行业分类 行业特征 发展历程 驱蚊用品是指用于居民防治 驱蚊用品可分为如下类别： 驱蚊用品行业特征包括“清 驱蚊用品行业 蚊虫的日常卫生杀虫用品… 凉经济”效益明显、驱蚊… 目前已达到 3个阶段 AI访谈 AI访谈 AI访谈 AI访谈 产业链分析 行业规模 政策梳理 竞争格局 驱蚊用品行业规模 驱蚊用品行业 驱蚊用品市场的竞争格局呈 上游分析 中游分析 下游分析 暂无评级报告 相关政策 5篇 现出多元化的特点，主要… AI访谈 AI访谈 SIZE数据 AI访谈 AI访谈 数据图表 摘要 夏秋季是蚊虫活动的高峰期，意味着中国的驱蚊市场在这段时间将会迎来旺季，各大品牌和电商平台纷纷推出各 种防蚊防虫产品，以满足消费者的需求。随着消费者健康观念、生活方式和消费水平的提高，更多消费者不再依 赖传统的驱蚊产品，而 ...